Summary
Definition
History and exam
Key diagnostic factors
- focal neurologic deficits
- focal neurologic symptoms (before or after seizure)
- premonitory sensation or experience (fear, epigastric sensation, déjà vu, jamais vu)
- temporary hemiparesis
- temporary aphasia
- fever, nuchal rigidity, altered mental status
Other diagnostic factors
- neurocutaneous findings of neurologic disease
Risk factors
- family history (extended or immediate) of generalized-onset epilepsy
- previous central nervous system (CNS) infection
- head trauma
- CNS lesion
- stroke
- prenatal or perinatal brain insult
- intellectual disability
- HIV
- prior seizure events or suspected seizure events
- history of substance use
- preterm birth
- multiple or complicated febrile seizures
Diagnostic tests
1st tests to order
- electroencephalogram (EEG)
- blood glucose
- CBC
- electrolyte panel
- toxicology screen
- head CT
Tests to consider
- MRI brain
- lumbar puncture
- serum creatine kinase (CK)
Treatment algorithm
acute repetitive seizures: in the community
acute repetitive seizures: in the hospital
≥2 unprovoked generalized tonic-clonic seizures (GTCSs) without syndromic diagnosis
≥2 unprovoked GTCSs with focal-onset epilepsy
≥2 unprovoked GTCSs with generalized-onset epilepsy
Contributors
Authors
Abdulrahman Alwaki, MD
Assistant Professor of Neurology
Emory University School of Medicine
Atlanta
GA
Disclosures
AA declares that he has no competing interests.
Daniel Winkel, MD
Assistant Professor of Neurology
Emory University School of Medicine
Atlanta
GA
Disclosures
DW receives consulting fees from NextSense, Inc.
Acknowledgements
Dr Abdulrahman Alwaki and Dr Daniel Winkel would like to gratefully acknowledge Dr Vikram R. Rao, Dr John D. Hixson, and Dr Daniel H. Lowenstein, previous contributors to this topic.
Disclosures
VRR has served as a paid consultant for NeuroPace, Inc., manufacturer of the Responsive Neurostimulation (RNS) System. VRR is also an author of several references cited in this topic. JDH has received research funding and consultancy funds from UCB Inc. DHL declares that he has no competing interests.
Peer reviewers
Mauricio F. Villamar, MD, FACNS
Assistant Professor of Neurology and Clinician Educator
The Warren Alpert Medical School of Brown University
Providence
RI
Disclosures
MFV declares that he has no competing interests.
Ranmal Samarasinghe, MD, PhD
Assistant Professor
Department of Neurology
David Geffen School of Medicine
UCLA
Los Angeles
CA
Disclosures
RS declares that he has no competing interests.
Edward Barry Bromfield, MD
Chief
Division of Epilepsy and Sleep
Department of Neurology
Brigham and Women's Hospital
Associate Professor of Neurology
Harvard Medical School
Boston
MA
Disclosures
EBB has received speaking fees from ICR Pharma, Novartis, Abbott Laboratories, GlaxoSmithKline, and Pfizer. He has received consulting fees from ICR Pharma, Genzyme, and Spherics, and research funding from UCB Pharma. Unfortunately we have since been made aware that EBB is deceased.
Roderick Duncan, MD, PhD, FRCP
Honorary Clinical Senior Lecturer
University of Glasgow
Institute of Neurological Sciences
Glasgow
UK
Disclosures
Not disclosed.
Differentials
- Functional seizures (nonepileptic seizures)
- Convulsive syncope
- Cardiac arrhythmia
More DifferentialsGuidelines
- Antiseizure medication withdrawal in seizure-free patients: practice advisory update summary
- Gynecologic management of adolescents and young women with seizure disorders
More GuidelinesPatient information
Epilepsy: what is it?
Epilepsy: what treatments work?
More Patient informationVideos
Diagnostic lumbar puncture in adults: animated demonstration
Venepuncture and phlebotomy: animated demonstration
More videos- Log in or subscribe to access all of BMJ Best Practice
Use of this content is subject to our disclaimer